Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients

Eelco P.M. Wijdicks, Linda J. Dahlke, Russell H. Wiesner

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Neoral is a new formulation of cyclosporine that permits reliable absorption in patients with external biliary drainage. The authors reviewed 227 liver transplant patients receiving primary treatment with Neoral. Headache occurred in 24 patients (11%), mild tremors in 12 patients, paresthesia in 5 patients, acute confusional state in 4 patients, and seizures in 2 patients. It is apparent that Neoral has profoundly reduced the severity of neurotoxicity in liver transplant recipients.

Original languageEnglish (US)
Pages (from-to)1708-1710
Number of pages3
JournalNeurology
Volume52
Issue number8
StatePublished - May 12 1999

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients'. Together they form a unique fingerprint.

  • Cite this

    Wijdicks, E. P. M., Dahlke, L. J., & Wiesner, R. H. (1999). Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients. Neurology, 52(8), 1708-1710.